A retrospective analysis of 350 cases of parotid gland tumors and the value of ultrasound in the diagnosis of benign and malignant parotid gland tumors

Abstract

Objective: To retrospective analysis of the epidemiological and clinical characteristics of parotid gland tumors, and to explore the value of ultrasound in the differentiation of benign and malignant parotid gland tumors.

Methods: The clinical data of 350 patients with parotid gland tumors in our hospital from 2002 to 2022 were retrospectively analyzed. These patients were examined by ultrasound. The postoperative pathological test results were used as the “gold standard” to verify and analyze the value of color Doppler ultrasound in the differential diagnosis of benign and malignant parotid tumors (PT).

Results: The male-to-female ratio of 350 patients with parotid gland tumors was 1.16:1. The age of patients ranged from 12 to 87 years old. Patients aged 40–65 years accounted for 54.6%, which was the most common age of parotid gland tumors. Among 350 cases, 259 were benign and 91 were malignant. The top three benign PTs were pleomorphic adenoma, Warthin tumor, and basal cell adenoma. The top three malignant tumors were mucoepidermoid carcinoma, acinar cell carcinoma, and adenoid cystic carcinoma. The specificity, sensitivity, accuracy, positive predictive value, and negative predictive value of ultrasonography in the diagnosis of benign and malignant parotid masses were 96.53%, 69.23%, 89.43%, 87.50%, and 87.72%, respectively.

Conclusion: The pathological types of parotid gland tumors are complex and diverse. Ultrasonography has high accuracy in the diagnosis of PT, which can provide important evidence for the differentiation of benign and malignant PT, and then assist in the clinical selection of individualized surgical programs.

Keywords

benign and malignant diagnosis / parotid gland tumor / retrospective analysis / ultrasound

References

[1] Seethala RR, Stenman G. Update from the 4th edition of the World Health Organization classification of head and neck tumours: tumors of the salivary gland. Head Neck Pathol. 2017;11(1):55-67.

[2] Lyu HX, Wang ZR, Gao YQ, Yu M, Li BQ, Zhang ZB. [Clinical pathologic analysis on 3 724 cases of salivary gland tumors]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2019;54(1):10-16. Chinese.

[3] Zhao ZG, Gao D, Wang J, Zhang LP. [Retrospective analysis of 896 cases of parotid gland tumor]. Shang Hai Kou Qiang Yi Xue. 2017;26(6):605-609. Chinese.

[4] Maahs GS, Oppermann Pde O, Maahs LG, Machado Filho G, Ronchi AD. Parotid gland tumors: a retrospective study of 154 patients. Braz J Otorhinolaryngol. 2015;81(3):301-306.

[5] Yan M, Xu D, Chen L, Zhou L. Comparative study of qualitative and quantitative analyses of contrast-enhanced ultrasound and the diagnostic value of B-mode and color Doppler for common benign tumors in the parotid gland. Front Oncol. 2021;11:669542.

[6] Ellis GL, Auclair PL, Gnepp DR, eds. Surgical Pathology of the Salivary Glands. WB Saunders;1991.

[7] Yu G, Ma D. [Research status of salivary gland diseases in China]. Chin J Stomatology, 2003, 38(2):81-84. Chinese.

[8] Eveson JW, Cawson RA. Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 1985;146(1):51-58.

[9] Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg. 1986;8(3):177-184.

[10] Takahama A, De Almeida OP, Kowalski LP. Parotid neoplasms: analysis of 600 patients attended at a single institution. Braz J Otorhinolaryngol. 2009;75(4):497-501.

[11] Ito FA, Ito K, Vargas PA, de Almeida OP, Lopes MA. Salivary gland tumors in a Brazilian population: a retrospective study of 496 cases. Int J Oral Maxillofac Surg. 2005;34(5):533-536.

[12] Comprehensive Analysis of Parotid Mass: A Retrospective Study of 369 Cases.

[13] Williams NP, Boyd DL, Choy L, Hanchard B. Salivary gland lesions: a Jamaican perspective. W Indian Med J. 2000;50:62-65.

[14] Lin CC, T sai MH, Huang CC, Hua CH, T seng HC, Huang ST. Parotid tumors: a 10 year experience. Am J Otolaryngol. 2008;29(2):94-100.

[15] de Ru JA, Plantinga RF, Majoor MH, et al. Warthin’s tumour and smoking. B-ENT. 2005;1(2):63-66.

[16] Psychogios G, Vlastos I, Thölken R, Zenk J. Warthin’s tumour seems to be the most common benign neoplasm of the parotid gland in Germany. Eur Arch Oto-Rhino-Laryngol. 2020;277(7):2081-2084.

[17] Roh JL, Kim HS, Park CI. Randomized clinical trial comparing partial parotidectomy versus superficial or total parotidectomy [J]. Br J Surg, 2007, 94(9):1081-1087.

[18] Bisdas S, Baghi M, Wagenblast J, et al. Differentiation of benign and malignant parotid tumors using deconvolution-based perfusion CT imaging: feasibility of the method and initial result. Eur J Radiol, 2007, 64(2):258-265.

[19] Stoia S, Băciuţ G, Lenghel M, et al. Ultrasonography techniques in the preoperative diagnosis of parotid gland tumors - an updated review of the literature. Med Ultrason. 2021;23(2):194-202.

[20] Huang HT, Liu HW, Wang R, Hu M. [A retrospective analysis of 412 cases of malignant tumors in parotid gland]. Shang Hai Kou Qiang Yi Xue. 2014;23(3):340-345. Chinese.

[21] Rzepakowska A, Osuch-Wójcikiewicz E, Sobol M, Cruz R, Sielska-Badurek E, Niemczyk K. The differential diagnosis of parotid gland tumors with high-resolution ultrasound in otolaryngological practice. Eur Arch Oto-Rhino-Laryngol. 2017;274(8):3231-3240.

[22] Takahama Junior A, Almeida OP, Kowalski LP. Parotid neoplasms: analysis of 600 patients attended at a single institution. Braz J Otorhinolaryngol. 2009;75(4):497-501.

RIGHTS & PERMISSIONS

2024 The Authors. Eye & ENT Research published by John Wiley & Sons Australia, Ltd on behalf of Higher Education Press.